John S. Yu
CEO and Chairman at Kairos Pharma Ltd.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Kairos Pharma Ltd., 2 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Kairos Pharma Ltd. June 10, 202599.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 8, 2025 | Kairos Pharma Ltd. | Grant or award | +190,840 | — | — |
| Jan 1, 2025 | Kairos Pharma Ltd. | Grant or award | +14,000 | — | — |
| Nov 20, 2024 | Kairos Pharma Ltd. | Open-market purchase | +4,000 | $1.44 | $5,760 |
Questions about John S. Yu
What boards is John S. Yu on?
John S. Yu sits on the board of Kairos Pharma Ltd.
What company is John S. Yu the CEO of?
John S. Yu has been CEO and Chairman of Kairos Pharma Ltd. since September 2024.
How long has John S. Yu served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.